Drugs / i-PRF
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT06314256 Comparator | Apr 2024 → Jun 2025 | gingival recession | Altinbas University | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | i-PRF | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06314256 ↗ |
| Modality | Other / unclassified | “Platelet Rich Fibrin (PRF) is an autologous, membrane-form product prepared by centrifugation of the patient's own blood.” NCT06314256 ↗ |
| Route | Other | “Injection of 0.1-0.2 ml per interdental papilla 3 times with 3-week interval.” NCT06314256 ↗ |